잠시만 기다려 주세요. 로딩중입니다.

Oncologic and obstetric outcomes of conservative surgery for borderline ovarian tumors in women of reproductive age

대한산부인과학회지 2017년 60권 3호 p.289 ~ 295
이세연, 최민철, Kwon Bo-Ram, Jung Sang-Geun, 박현, 주원덕, 이찬, 이제호, Lee Joon-Mo,
소속 상세정보
이세연 ( Lee Se-Yun ) - CHA University CHA Bundang Medical Center Department of Obstetrics and Gynecology
최민철 ( Choi Min-Chul ) - CHA University CHA Bundang Medical Center Comprehensive Gynecologic Cancer Center
 ( Kwon Bo-Ram ) - CHA University CHA Bundang Medical Center Department of Obstetrics and Gynecology
 ( Jung Sang-Geun ) - CHA University CHA Bundang Medical Center Department of Obstetrics and Gynecology
박현 ( Park Hyun ) - CHA University CHA Bundang Medical Center Comprehensive Gynecologic Cancer Center
주원덕 ( Joo Won-Duk ) - CHA University CHA Bundang Medical Center Comprehensive Gynecologic Cancer Center
이찬 ( Lee Chan ) - CHA University CHA Bundang Medical Center Comprehensive Gynecologic Cancer Center
이제호 ( Lee Je-Ho ) - CHA University CHA Bundang Medical Center Comprehensive Gynecologic Cancer Center
 ( Lee Joon-Mo ) - CHA University CHA Bundang Medical Center Comprehensive Gynecologic Cancer Center

Abstract


Objective: To compare the oncologic and obstetric outcomes in reproductive-age females with borderline ovarian tumors (BOTs) treated with cyst enucleation (CE) or unilateral salpingo-oophorectomy (USO).

Methods: The medical records of patients with BOTs treated between 1998 and 2014 were retrospectively reviewed. The recurrence rates in the USO and CE groups were compared, and the postoperative obstetric outcomes were assessed via telephone survey.

Results: Eighty-nine patients with BOTs underwent USO, and 19 underwent CE. Of these, six patients had recurrent BOTs. The recurrence rate was significantly lower in the USO group (3/89, 3.4%) than in the CE group (3/19, 15.8%) (P=0.032). All patients with recurrent disease were successfully treated with further surgery. Of the 76 patients interviewed by telephone, 71 (93.4%) resumed regular menstruation after surgery. Twenty-six of the 32 patients (81.3%) who attempted to conceive had successful pregnancies. USO (19/24, 79.2%), like CE (7/8, 87.5%), resulted in favorable pregnancy rates for patients with BOTs.

Conclusion: USO is a suitable fertility-preserving surgery for women with BOTs. CE is also an acceptable option for select patients.

키워드

Borderline ovarian tumor; Fertility preservation; Pregnancy; Recurrence

원문 및 링크아웃 정보

  

등재저널 정보

KCI
KoreaMed
KAMS